David Sher, M.D.

Vice Chair of Clinical Operations and Quality, Medical Director of Radiation Oncology, Chief of Head and Neck Radiation Oncology Service

Professor

Endowed Title: Barbara Crittenden Professorship in Cancer Research
School: Medical School
Department: Radiation Oncology

You have reached the Academic Profile.

For more information on the doctor and patient care, please visit the clinical profile.

Education

Medical School: Harvard Medical School (2003)
Internship: Beth Israel Deaconess Medical Center (2004), Internal Medicine
Residency: Harvard/Brigham and Women's Hospital/Massachusetts General Hospital (2008), Radiation Oncology

Publications

Relationship Between Elective Neck Irradiation and Severe Lymphopenia in Patients Treated With Head and Neck Chemoradiotherapy: Mickel TA, Moon DH, Avkshtol V, Pham NL, Shah JL, Hughes RS, Sumer BD, Sher DJ Clinical Oncology 2025 Aug 44
Associations between dosimetry and patient-reported outcomes in oropharyngeal cancer: post hoc analysis of elective neck de-escalation trials: Tuo A, Moon DH, Avkshtol V, Shah JL, Pham NL, Sher DJ Radiotherapy and Oncology 2025 Aug 209
We Have Not Yet Begun to Fight!: Sher DJ, Lin MH International Journal of Radiation Oncology Biology Physics 2025 Jul 122 534-535
TransAnaNet: Transformer-based anatomy change prediction network for head and neck cancer radiotherapy: Chen M, Wang K, Dohopolski M, Morgan H, Sher D, Wang J Medical physics 2025 May 52 3015-3029
Enhanced dose prediction for head and neck cancer artificial intelligence-driven radiotherapy based on transfer learning with limited training data: Wang HJ, Maniscalco A, Sher D, Lin MH, Jiang S, Nguyen D Journal of applied clinical medical physics 2025 May 26
Closing the gap in plan quality: Leveraging deep-learning dose prediction for adaptive radiotherapy: Domal SJ, Maniscalco A, Visak J, Dohopolski M, Moon D, Avkshtol V, Nguyen D, Jiang S, Sher D, Lin MH Journal of applied clinical medical physics 2025 May 26
Postoperative Radiotherapy ± Cetuximab for Intermediate-Risk Head and Neck Cancer: Author Collaboration NO, Machtay M, Torres-Saavedra PA, Thorstad W, Nguyen-Tân PF, Siu LL, Holsinger FC, El-Naggar A, Chung C, Cmelak A, Burtness B, Bednarz G, Quon H, Breen SL, Gwede CK, Dicker AP, Yao M, Jordan RC, Dorth J, Lee N, Chan JW, Dunlap N, Bar-Ad V, Stokes WA, Chakravarti A, Sher D, Rao S, Harris J, Yom SS, Le QT, Bowles DW, Jones CU, Krempl GA, Lominska C, Ma DJ, Mell LK, Raben A, Samuels S, Spencer S, Takiar V, Wilke CT, Young MR Journal of Clinical Oncology 2025 Apr 43 1474-1487
Contour uncertainty assessment for MD-omitted daily adaptive online head and neck radiotherapy: Liao CY, Maniscalco AM, Zhao H, Bai T, Choi B, Moon D, Yang D, Wang J, Zhong X, Nguyen D, Godley A, Jiang SB, Sher D, Lin MH Radiotherapy and Oncology 2025 Apr 205
Nodal Yield From Neck Dissection Predicts the Anti-Tumor Immune Response in Head and Neck Cancers: Chen S, Pyne JM, Liu Y, Abraham Y, Wen Z, Palsgrove D, Xiao G, Truelson J, Myers L, Tillman B, Day A, Gordin E, Stankova L, Xie Y, Sher D, Bishop J, Gao J, Sumer BD Head and Neck 2025 Apr 47 1199-1208
The Future of Head and Neck Radiotherapy: Not Your Father's Three-Field: Sher DJ, Mowery YM Seminars in Radiation Oncology 2025 Apr 35 141-142